Get started
Author

Nancy Thiry

Observed names: N Thiry, N. Thiry, Thiry Nancy, Thiry, Nancy
ORCID: 0009-0001-9089-8517
Observed ORCID: 0009-0001-9089-8517
OpenAlex ID: A5034050655
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions
2011 · Irina Cleemput, Mattias Neyt, et al. · International Journal of Technology Assessment in Health Care · 134
Economic Evaluations of Varicella Vaccination Programmes: A Review of the Literature
2003 · Nancy Thiry, Philippe Beutels, et al. · PharmacoEconomics · 91
Convincing or confusing?
2006 · Philippe Beutels, Nancy Thiry, et al. · Vaccine · 72
Varicella vaccination in Europe: are we ready for a universal childhood programme?
2007 · Nitu Sengupta, Robert Booy, et al. · European Journal of Pediatrics · 61
The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium)
2002 · Nancy Thiry, Philippe Beutels, et al. · European Journal of Pediatrics · 51
An economic evaluation of varicella vaccination in Italian adolescents
2004 · Nancy Thiry, Philippe Beutels, et al. · Vaccine · 46
Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysis
2023 · Renate Zeevaert, Nancy Thiry, et al. · Vaccine X · 39
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium
2018 · Lander Willem, Adriaan Blommaert, et al. · Human Vaccines & Immunotherapeutics · 31
PDF
Threshold values for cost-effectiveness in health care
2009 · Irina Cleemput, Mattias Neyt, et al. · 31
PDF
Belgian guidelines for budget impact analyses
2015 · M. Neyt, I. Cleemput, et al. · Acta Clinica Belgica · 29
Cost-effectiveness of human papillomavirus vaccination in Belgium: Do not forget about cervical cancer screening
2009 · Nancy Thiry, Chris De Laet, et al. · International Journal of Technology Assessment in Health Care · 29
Belgian Guidelines for Economic Evaluations: Second Edition
2014 · Nancy Thiry, Mattias Neyt, et al. · International Journal of Technology Assessment in Health Care · 27
An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied
2020 · Mattias Neyt, Sophie Gerkens, et al. · Health Policy · 23
PDF
Cost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context
2008 · Mattias Neyt, Nancy Thiry, et al. · Applied Health Economics and Health Policy · 22
Belgian guidelines for economic evaluations and budget impact analyses: third edition
2025 · Mattias Neyt, Nancy Thiry, et al. · 20
PDF
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
2010 · Mattias Neyt, Stephan Devriese, et al. · BMC Pulmonary Medicine · 19
PDF
Benefits and costs of innovative oncology drugs in Belgium (2004-2017)
2021 · Mattias Neyt, Carl Devos, et al. · 16
Belgian guidelines for economic evaluations and budget impact analyses: second edition
2015 · Irina Cleemput, Mattias Neyt, et al. · 16
PDF
Valeurs seuils pour le rapport coût-efficacité en soins de santé
2009 · Irina Cleemput, Mattias Neyt, et al. · 12
PDF
Cervical cancer screening program and human papillomavirus (HPV) testing, part ii
2015 · Marc Arbyn, Annemie Haelens, et al. · 10
PDF
Introduction of emerging medical devices on the market: A new procedure in Belgium
2007 · Imgard Vinck, Mattias Neyt, et al. · International Journal of Technology Assessment in Health Care · 10
Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood.
2011 · Philippe Beutels, Adriaan Blommaert, et al. · 9
PDF
Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
2023 · Leen Verleye, Diego Castanares-Zapatero, et al. · International Journal of Gynecological Cancer · 8
Use of pneumococcal vaccines in the elderly: an economic evaluation
2016 · Adriaan Blommaert, Germaine Hanquet, et al. · 8
PDF
Recommendations for the Use of the 23-valent Polysaccharide Pneumococcal Vaccine in Adults: a Belgian Consensus Report.
2005 · W.E. Peetermans, N. Van de Vyver, et al. · Acta Clinica Belgica · 8
Works count: 157
Citation count: 973
H-index: 16
I10-index: 21
Year
Topic
Type